Vital Signs - Healthcare News - The Analysts Perspective July 2013 Issue

Regular Price: USD 450.00

Special Price USD 382.50

15% OFF

* Required Fields

Regular Price: USD 450.00

Special Price USD 382.50


Be the first to review this product

This issue of Vital Signs, released on July 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

Table of Contents

Vital Signs - Healthcare News - The Analyst's Perspective July 2013 IssueVital Signs: July 31 2013This week's issue

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.